search

Active clinical trials for "Retinitis Pigmentosa"

Results 71-80 of 222

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated...

Inherited Retinal DegenerationRetinitis Pigmentosa

This is an international, multicenter study with two components: Registry A standardized genetic screening and a prospective, standardized, cross-sectional clinical data collection Enrollment is open to all genes on the RD Rare Gene List Natural History Study A prospective, standardized, longitudinal Natural History Study Enrollment opens gene-by-gene, based on funding and within-gene Registry enrollment The study objectives are as follows. Registry Objectives Genotype Characterization Cross-Sectional Phenotype Characterization (within gene) Establish a Link to My Retina Tracker Registry (MRTR) Ancillary Exploratory Studies - Pooling of Genes Natural History Study Objectives Natural History (within gene) Structure-Function Relationship (within gene) Risk Factors for Progression (within gene) Ancillary Exploratory Studies - Pooling of Genes

Recruiting31 enrollment criteria

Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer

Retinal DystrophiesRetinitis Pigmentosa1 more

Objective perimetry can better monitor visual field defects in retinal dystrophy and Glaucoma patients than conventional subjective perimetry. The PLR ( Pupil Light Reflex to short and long wavelength stimuli should be significantly lower compared to healthy participants in areas of visual field defects in retinal dystrophy and Glaucoma patients.

Recruiting23 enrollment criteria

High Resolution Retina Imaging

Retinitis PigmentosaMaculopathy7 more

To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera

Recruiting4 enrollment criteria

Natural History Study of Retinitis Pigmentosa Type 11

Retinitis Pigmentosa 11Retinitis Pigmentosa

Observational study of patients with retinitis pigmentosa type 11

Recruiting4 enrollment criteria

CNGB1 and Allied Disorders

Retinitis Pigmentosa Associated With CNGB1 Mutations

Mutations in the rod-expressed gene, cyclic nucleotide-gated channel beta subunit (CNGB1) and associated inborn errors in metabolism are causes of retinal disease that causes progressive loss of vision. Retinitis pigmentosa (RP) is a major cause of untreatable blindness associated with CNGB1 (CNGB1-RP). RP involves the death of photoreceptor cells that can be caused by mutations in a number of different genes. Treatment by gene therapy could prevent blindness in cases of inherited retinal dystrophies including RP. In the future RP due to mutations in CNGB1 may be treatable by gene therapy since this form of photoreceptor degeneration involves a slow loss of rod photoreceptor cells. This provides a wide window of opportunity for the identification of patients and initiation of treatment. Our efforts are directed toward developing gene therapy as a treatment. To this end, our objective is to better understand the disease process of CNGB1-RP and other allied inherited disorders so that we can develop clinical tests to measure the outcomes of treatment.

Recruiting2 enrollment criteria

Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing....

Retinitis Pigmentosa

The retinitis pigmentosa (RP) are genetic conditions that cause retinal degeneration leading to severe low vision and is the leading cause of consultation in reference centers dedicated to the ophthalmic genetics. These rare diseases are characterized by a triple heterogeneity (clinical, genetic and molecular), which made them unreachable by traditional molecular diagnostic sequencing technology by the large number of genes to be tested (> 190). The advent of high-throughput sequencing (NGS) and targeted capture has opened unexpected possibilities of investigation and ultimately to improve the care of patients. This project aims to study the genetic and molecular epidemiology of an interregional french (grand EST) cohort of patients. Patients receive a detailed retinal phenotype (visual acuity, visual field, photographs of the fundus and ERG). Their DNA will be analyzed by NGS targets the 190 known genes (https://sph.uth.edu/retnet/). This research will provide a molecular epidemiological cohort study compared to prior publications on the frequency of genes involved. The benefit for patients is important to: establish a mode of transmission of the disease and optimize genetic counseling (currently very empirical); establish phenotype-genotype correlations in the French population (very few studies to date) and from the data of international literature; identify patients likely to be included in future therapeutic protocols of research; identify patients with significant potential for future projects to identify new genes. The primary purpose of the protocol is to use high throughput sequencing to identify pathogenic variants in genes involved in RP. The secondary purposes will be the following: Determining the diagnostic yield Study the genotype-phenotype correlation. The secondary purposes will be the following: Determining the diagnostic yield Study the genotype-phenotype correlation

Recruiting10 enrollment criteria

Inherited Retinal Degenerative Disease Registry

Eye Diseases HereditaryRetinal Disease26 more

The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by the Foundation. It is a patient-initiated registry accessible via a secure on-line portal at www.MyRetinaTracker.org. Affected individuals who register are guided to create a profile that captures their perspective on their retinal disease and its progress; family history; genetic testing results; preventive measures; general health and interest in participation in research studies. The participants may also choose to ask their clinician to add clinical measurements and results at each clinical visit. Participants are urged to update the information regularly to create longitudinal records of their disease, from their own perspective, and their clinical progress. The overall goals of the Registry are: to better understand the diversity within the inherited retinal degenerative diseases; to understand the prevalence of the different diseases and gene variants; to assist in the establishment of genotype-phenotype relationships; to help understand the natural history of the diseases; to help accelerate research and development of clinical trials for treatments; and to provide a tool to investigators that can assist with recruitment for research studies and clinical trials.

Recruiting5 enrollment criteria

Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

Retinitis PigmentosaRetinal Dystrophy

This is a prospective Multi-Center Observational Study to assess the reliability and validity of the Multi-Luminance Y-Mobility Test (MLYMT) and Multi-Luminance Shape Discrimination Study (MLSDT) Main Outcome Measures: (i) Performance scores in normal and severely visually impaired subjects with a clinical diagnosis of retinitis pigmentosa (RP) on MLYMT and MLSDT at multiple luminance levels and (ii) reliability and content validity of MLYMT and MLSDT.

Active11 enrollment criteria

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis...

Retinitis Pigmentosa

The rod-cone dystrophies (often referred to as retinitis pigmentosa (RP)) are a clinically and genetically heterogeneous group of disorders in which there is progressive loss of rod and later cone photoreceptor function leading to severe visual impairment. RP usually occurs as an isolated retinal disorder, but it may also be seen in association with systemic abnormalities.

Active6 enrollment criteria

NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases

Retinitis PigmentosaRetinal Degeneration

The study objective is to demonstrate safety of the NR 600 System, and to evaluate the performance of the device in restoring visual activity of daily living in subjects with retinal degenerative diseases and severe visual impairment

Terminated20 enrollment criteria
1...789...23

Need Help? Contact our team!


We'll reach out to this number within 24 hrs